RecruitingPhase 2NCT06570798
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
Sponsor: Amgen
Seattle, WA · +17 more sites
5 recruiting rheumatoid arthritis studies with a site in Seattle, WA.
Sponsor: Amgen
Seattle, WA · +17 more sites
Sponsor: Duke University
Seattle, WA · +74 more sites
Sponsor: AstraZeneca
Seattle, WA · +7 more sites
Sponsor: Children's Hospital of Philadelphia
Seattle, WA · +22 more sites
Sponsor: Bristol-Myers Squibb
Seattle, WA · +9 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.